ATE371655T1 - Farnesyl-protein-transferaseinhibitoren - Google Patents

Farnesyl-protein-transferaseinhibitoren

Info

Publication number
ATE371655T1
ATE371655T1 AT01985496T AT01985496T ATE371655T1 AT E371655 T1 ATE371655 T1 AT E371655T1 AT 01985496 T AT01985496 T AT 01985496T AT 01985496 T AT01985496 T AT 01985496T AT E371655 T1 ATE371655 T1 AT E371655T1
Authority
AT
Austria
Prior art keywords
transferas
inhibitors
farnesyl protein
farnesyl
protein
Prior art date
Application number
AT01985496T
Other languages
English (en)
Inventor
F Njoroge
Bancha Vibulbhan
Viyyoor Girijavallabhan
Xiongwei Shi
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE371655T1 publication Critical patent/ATE371655T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01985496T 2000-11-29 2001-11-27 Farnesyl-protein-transferaseinhibitoren ATE371655T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25397100P 2000-11-29 2000-11-29

Publications (1)

Publication Number Publication Date
ATE371655T1 true ATE371655T1 (de) 2007-09-15

Family

ID=22962414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01985496T ATE371655T1 (de) 2000-11-29 2001-11-27 Farnesyl-protein-transferaseinhibitoren

Country Status (20)

Country Link
US (1) US6528523B2 (de)
EP (1) EP1337522B1 (de)
JP (1) JP2004514717A (de)
KR (1) KR20030060939A (de)
CN (1) CN1198816C (de)
AR (1) AR035660A1 (de)
AT (1) ATE371655T1 (de)
AU (2) AU3514302A (de)
CA (1) CA2429720C (de)
DE (1) DE60130239T2 (de)
ES (1) ES2291368T3 (de)
HK (1) HK1054226A1 (de)
HU (1) HUP0302104A2 (de)
IL (1) IL155668A0 (de)
MX (1) MXPA03004878A (de)
NZ (1) NZ525572A (de)
PE (1) PE20020635A1 (de)
TW (1) TWI225058B (de)
WO (1) WO2002044164A1 (de)
ZA (1) ZA200303635B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2546727C (en) 2003-11-20 2012-10-02 Children's Hospital Medical Center Gtpase inhibitors and methods of use
EP1920048A4 (de) 2005-07-29 2009-12-09 Childrens Hosp Medical Center Gtase-hemmer und verwendungsverfahren und kristallstruktur von rac-1-gtase
WO2013166043A1 (en) 2012-05-02 2013-11-07 Children's Hospital Medical Center Rejuvenation of precursor cells
US10028503B2 (en) 2014-06-18 2018-07-24 Children's Hospital Medical Center Platelet storage methods and compositions for same

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE210653T1 (de) * 1993-10-15 2001-12-15 Schering Corp Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US6365588B1 (en) 1993-10-15 2002-04-02 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5684013A (en) 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5801175A (en) 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5874442A (en) 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
WO1997023478A1 (en) * 1995-12-22 1997-07-03 Schering Corporation Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
US5784442A (en) 1996-02-02 1998-07-21 Telefonaktiebologet Lm Ericsson (Publ) System and method for real-time billing in a radio telecommunications network
US5925757A (en) * 1996-07-26 1999-07-20 Schering Corporation Method for preparing carboxamides
US5945429A (en) 1996-09-13 1999-08-31 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6071907A (en) 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US6030982A (en) 1996-09-13 2000-02-29 Schering Corporationm Compounds useful for inhibition of farnesyl protein transferase
US6040305A (en) 1996-09-13 2000-03-21 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5985879A (en) 1996-09-13 1999-11-16 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
US6358968B1 (en) 1997-06-17 2002-03-19 Schering Corporation N-substituted urea inhibitors of farnesyl-protein transferase
US6051582A (en) 1997-06-17 2000-04-18 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
WO1998057949A1 (en) * 1997-06-17 1998-12-23 Schering Corporation Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase
US6159984A (en) 1997-06-17 2000-12-12 Schering Corporation Farnesyl protein transferase inhibitors
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5939416A (en) 1997-06-17 1999-08-17 Schering Corporation Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
US5925639A (en) 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
NZ501618A (en) * 1997-06-17 2001-10-26 Schering Corp Benzo(5,6) cyclohepta(1,2-b)pyridine derivatives and their use as inhibitors of abnormal cell growth (e.g. cancer) and as inhibitors of farnesyl protein transferase
US6239140B1 (en) 1997-06-17 2001-05-29 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5852034A (en) 1997-06-17 1998-12-22 Schering Corporation Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6221322B1 (en) 1997-11-27 2001-04-24 Dowa Mining Co., Ltd Strontium nitrate and method for manufacturing same
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
US6432959B1 (en) 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US6410451B2 (en) 1999-09-27 2002-06-25 Lam Research Corporation Techniques for improving etching in a plasma processing chamber

Also Published As

Publication number Publication date
CN1476444A (zh) 2004-02-18
CN1198816C (zh) 2005-04-27
NZ525572A (en) 2004-11-26
PE20020635A1 (es) 2002-07-11
ZA200303635B (en) 2004-08-12
TWI225058B (en) 2004-12-11
CA2429720C (en) 2009-12-29
AR035660A1 (es) 2004-06-23
KR20030060939A (ko) 2003-07-16
HK1054226A1 (zh) 2003-11-21
HUP0302104A2 (hu) 2003-09-29
CA2429720A1 (en) 2002-06-06
DE60130239D1 (en) 2007-10-11
DE60130239T2 (de) 2008-05-21
JP2004514717A (ja) 2004-05-20
ES2291368T3 (es) 2008-03-01
WO2002044164A1 (en) 2002-06-06
AU3514302A (en) 2002-06-11
MXPA03004878A (es) 2003-08-19
IL155668A0 (en) 2003-11-23
EP1337522B1 (de) 2007-08-29
AU2002235143B2 (en) 2006-03-02
US20020115679A1 (en) 2002-08-22
EP1337522A1 (de) 2003-08-27
US6528523B2 (en) 2003-03-04

Similar Documents

Publication Publication Date Title
CY2012007I2 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
DE60234125D1 (de) E inhibitoren
DE60129794D1 (de) Pyrrol substituierte indolin-2-on protein kinase inhibitoren
PT1370553E (pt) Inibidores de rhoquinase
NO20034045L (no) Metallproteinase-inhibitorer
NO20034032L (no) Metallproteinase-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
DE69924876D1 (de) Farnesyl protein transferase inhibitoren
ATE255114T1 (de) Tricyclische proteinkinasehemmer
NO20025786L (no) Protaseinhibitorer
DK1339695T3 (da) Farnesyltransferase-inhibitorer
NO20025005D0 (no) Proteaseinhibitorer
NO20025281D0 (no) Peptid-deformylase-inhibitorer
DE50101588D1 (de) Klemmstück
ATE371655T1 (de) Farnesyl-protein-transferaseinhibitoren
IS6358A (is) Farnasýl transferasa latar
AR028075A1 (es) Inhibidores de la peptido-desformilasa
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
NO20032328D0 (no) Proteaseinhibitorer
DK1296985T3 (da) Heteropolycykliske inhibitorer
SE0104413D0 (sv) New protein
ITIS20000001A1 (it) Shoes line
UA3972S (uk) Літак
ES1049033Y (es) Pinza higienica
SE0002139D0 (sv) Methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties